Page Information:
|
Page Title:
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group - PubMed
Page Description:
What's known on the subject? and What does the study add? Very few comparative studies to date evaluate the results of treatment options for prostate cancer using the most sensitive measurement tools. PSA has been identified as the most sensitive tool for measuring treatment effectiveness. To date, …
This Page is About:
pmid:22239226, doi:10.1111/j.1464-410X.2011.10827.x, Research Support, Non-U.S. Gov't, Review, Peter Grimm, Ignace Billiet, Stephen Langley, Brachytherapy / methods*, Disease Progression, Disease-Free Survival, Humans, Male, Neoplasm Staging, Prostate-Specific Antigen / metabolism*, Prostatectomy*, Prostatic Neoplasms* / diagnosis, Prostatic Neoplasms* / mortality, Prostatic Neoplasms* / therapy, Risk Factors, Survival Rate / trends, PubMed Abstract, NIH, NLM, NCBI, National Institutes of Health, National Center for Biotechnology Information, National Library of Medicine, MEDLINE
|
